TRIPS Council’s discussion on ‘Intellectual Property and Access to Medicines’
On 20 June 2001, the TRIPS Council held a special discussion on intellectual property and access to medicines, as part of its week-long regular meeting. This subject was put on the agenda at the request of the African Group — i.e. the African members of the °ÄÃÅÁùºÏ²Ê¹ÙÍø×ÊÁÏ.
SEE
ALSO:
> Second
meeting Sep 2001
> TRIPS issues:
Pharmaceuticals
and patents
> Fact sheet on
TRIPS
and pharmaceuticals
> A more technical explanation:
Pharmaceutical patents and the TRIPS Agreement
> Høsbjør workshop
on
affordable medicines
°ÄÃÅÁùºÏ²Ê¹ÙÍø×ÊÁÏ member governments have agreed to examine in greater detail the issues raised in their first special discussion on Intellectual Property and Access to Medicines on 20 June 2001, a meeting that the chairperson, Ambassador Boniface Chidyausiku of Zimbabwe described as “rich”. > 22 June 2001 press release
Governments share interpretations on TRIPS and public health
Unusually frank and detailed interpretations of the °ÄÃÅÁùºÏ²Ê¹ÙÍø×ÊÁÏ’s intellectual property agreement characterized the 20 June 2001 discussion on “Intellectual Property and Access to medicines” in °ÄÃÅÁùºÏ²Ê¹ÙÍø×ÊÁÏ’s TRIPS Council. > summary of discussion
Moore:
countries must feel secure that they can use TRIPS’ flexibility
°ÄÃÅÁùºÏ²Ê¹ÙÍø×ÊÁÏ Director-General Mike Moore says the special discussion on “Intellectual Property and Access to Medicines” should reinforce countries’ confidence in their right to use the flexibility written into the °ÄÃÅÁùºÏ²Ê¹ÙÍø×ÊÁÏ Agreement on Trade-Related Aspects of Intellectual Property Rights. > statement
Countries’
papers
> European
Union
> Africa Group, Barbados, Bolivia, Brazil, Dominican Republic, Ecuador, Honduras, India, Indonesia, Jamaica, Pakistan, Paraguay, Philippines, Peru, Sri Lanka, Thailand and Venezuela